(Q44813126)

6 December 2017

Olanzapine attenuates cue-elicited craving for tobacco (English)

1 reference

6 December 2017

3

Raymond Niaura

1 reference

6 December 2017

Kent E Hutchison

1

1 reference

6 December 2017

Marie-Christine Rutter

2

1 reference

6 December 2017

Robert M Swift

4

1 reference

6 December 2017

Wallace B Pickworth

5

1 reference

6 December 2017

Laura Sobik

6

1 reference

6 December 2017

1 October 2004

1 reference

6 December 2017

7

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

6 December 2017

175

1 reference

6 December 2017

4

1 reference

6 December 2017

407-413

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-004-1837-3

6 December 2017

0 references

cites work

Meta-analysis of cue-reactivity in addiction research

1 reference

12 December 2020

Individual differences in cue reactivity among smokers trying to quit: effects of gender and cue type.

1 reference

12 December 2020

A multi-dimensional analysis of cue-elicited craving in heavy smokers and tobacco chippers

1 reference

12 December 2020

Effects of cue exposure and deprivation on cognitive resources in smokers.

1 reference

12 December 2020

Clozapine decreases smoking in patients with chronic schizophrenia

1 reference

12 December 2020

The effects of dopaminergic D2 stimulation and blockade on smoking behavior

1 reference

12 December 2020

Naltrexone-induced alterations in human ethanol intoxication.

1 reference

12 December 2020

Relevance of cue reactivity to understanding alcohol and smoking relapse

1 reference

12 December 2020

Smoking cues decrease prepulse inhibition of the startle response and increase subjective craving in humans.

1 reference

12 December 2020

Smoking cessation: progress, priorities, and prospectus

1 reference

12 December 2020

Modulating tobacco smoking rates by dopaminergic stimulation and blockade

1 reference

12 December 2020

The DRD4 VNTR polymorphism influences reactivity to smoking cues

1 reference

12 December 2020

Placebo cigarettes in smoking research

1 reference

12 December 2020

Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers.

1 reference

12 December 2020

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

1 reference

12 December 2020

The effects of smoking high nicotine cigarettes on prepulse inhibition, startle latency, and subjective responses

1 reference

12 December 2020

Haloperidol increases smoking in patients with schizophrenia

1 reference

12 December 2020

Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging

1 reference

12 December 2020

Pharmacodynamic effects of new de-nicotinized cigarettes.

1 reference

12 December 2020

Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking

1 reference

12 December 2020

The effect of bupropion sustained-release on cigarette craving after smoking cessation

1 reference

12 December 2020

Smokers' reactions to interpersonal interaction and presentation of smoking cues

1 reference

12 December 2020

First lapses to smoking: within-subjects analysis of real-time reports

1 reference

12 December 2020

The measurement of drug craving

1 reference

12 December 2020

Nicotine intake in smokers increases following a single dose of haloperidol.

1 reference

12 December 2020

Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving

1 reference

12 December 2020

Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving

1 reference

12 December 2020

Missed opportunities to assist hospitalized smokers

1 reference

12 December 2020

Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol

1 reference

12 December 2020

Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction

1 reference

12 December 2020

The effect of bupropion on nicotine craving and withdrawal.

1 reference

12 December 2020

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey

1 reference

12 December 2020

Development and validation of the Biphasic Alcohol Effects Scale.

1 reference

12 December 2020

Clozapine and substance abuse in patients with schizophrenia

1 reference

12 December 2020

Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer.

1 reference

12 December 2020

Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes

1 reference

12 December 2020

A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes

1 reference

12 December 2020

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

1 reference

12 December 2020

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

1 reference

12 December 2020

Challenges in the manipulation, assessment and interpretation of craving relevant variables.

1 reference

12 December 2020

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

12 December 2020

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

1 reference

12 December 2020

The neurobiology of craving: implications for the understanding and treatment of addiction

1 reference

12 December 2020

Development and validation of brief measures of positive and negative affect: The PANAS scales

1 reference

12 December 2020

10.1007/S00213-004-1837-3

Identifiers

DOI

1 reference

6 December 2017

1 reference